Literature DB >> 32473665

COVID-19 in Africa: no room for complacency.

.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32473665      PMCID: PMC7255759          DOI: 10.1016/S0140-6736(20)31237-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
Despite over 100 000 confirmed cases and infections in every country, the passage of COVID-19 through the African continent remains somewhat enigmatic. High numbers of deaths were expected in the region due to fragile health systems, lack of access to preventive measures, barriers to testing, and potentially vulnerable populations. But, according to WHO, Africa is the least affected region globally, with 1·5% of the world's reported COVID-19 cases and 0·1% of the world's deaths. Although comparisons are inaccurate, mortality rates have been lower compared with outbreaks of similar size elsewhere. Many hypotheses have been suggested for this paradox, including sensitivity of the virus to ambient temperature, Africa's comparatively young population, lower rates of obesity, and familiarity with infectious disease outbreaks. Low levels of testing might be artificially lowering apparent infection rates. The situation in the continent is highly heterogeneous and progress varies considerably. In February, 2020, while many other countries were still dismissing the emerging outbreak, the African Union acted swiftly, endorsing a joint continental strategy in conjunction with WHO. The Africa Centres for Disease Control and Prevention had considerably expanded COVID-19 testing capabilities by the end of the month. Many African countries acted early, enforcing a lockdown and border closure. But these strict restrictions have not been without difficulty. Human rights organisations have voiced concerns about abusive implementation of lockdowns by police and military, including in South Africa. 71% of Africans work in the informal sector and many have no financial reserves. Ghana, Uganda, Kenya, and other countries have initiated emergency programmes for distribution of goods and Nigeria is also providing financial support to the most vulnerable people. Balancing the potential for food shortages, social unrest, and economic collapse, other countries, including Malawi and Ghana, have opted for no or only partial lockdowns. It is too early to fully understand the implications of these differing strategies, but the response of Tanzania has raised near universal concern, with no case numbers released for weeks and the endorsement of unproven herbal remedies by President John Magufuli. There is no room for complacency. Medical capacity within Africa will be rapidly overwhelmed if containment fails, but vertical efforts concentrated on this outbreak threaten other hard-won gains. As a result of this pandemic, 80 million children under the age of 1 year worldwide may be at risk of vaccine-preventable diseases, as routine immunisations have been disrupted in many countries, including Chad, Ethiopia, Nigeria, and South Sudan. The focus on COVID-19 must not detract from continued action in other areas of health. Interrupted vaccination campaigns in DR Congo might have cost more lives than Ebola infection. Repeating this scenario with COVID-19 on a continental scale must be avoided. This pandemic should underline the importance of universal health coverage over narrow responses. Despite a strong regional response, the repercussions of the global COVID-19 pandemic could hinder Africa's capacity to minimise deaths and economic disruption. The closure of international borders, disruption of flights and supply chains, and export bans restrict the ability of African countries to procure personal protective equipment, diagnostics, and essential food items, risking disease spread and famine. Many countries have responded with local solutions, such as development of cheap diagnostic tests in Senegal and establishing local supplies of masks in Ghana. Actions including suspension of tariffs on health-care products, establishment of supply corridors, and the easing of restrictions on food exports recommended by the UN must be adopted quickly. The World Bank estimates that up to 60 million people will be pushed into extreme poverty by the end of the year. Global market changes will affect exports, including oil and tourism, with a substantial impact in Africa. The UN Secretary-General has called for a comprehensive global response package, including across the board debt standstill and restructuring to support Africa's economic resilience. There is still potential for disaster in Africa, especially as countries begin to ease the strictest lockdowns. The COVID-19 pandemic enforces global power structures. The rest of the world has a role in supporting and enabling an effective and safe response, but as much as Africa faces unique difficulties, it also has unique strengths. There have been many national successes and an effective regional response. Future action needs to be Africa-led and the rest of the world should look to see what can be learned.
  18 in total

Review 1.  Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future.

Authors:  Olayinka O Ogunleye; Debashis Basu; Debjani Mueller; Jacqueline Sneddon; R Andrew Seaton; Adesola F Yinka-Ogunleye; Joshua Wamboga; Nenad Miljković; Julius C Mwita; Godfrey Mutashambara Rwegerera; Amos Massele; Okwen Patrick; Loveline Lum Niba; Melaine Nsaikila; Wafaa M Rashed; Mohamed Ali Hussein; Rehab Hegazy; Adefolarin A Amu; Baffour Boaten Boahen-Boaten; Zinhle Matsebula; Prudence Gwebu; Bongani Chirigo; Nongabisa Mkhabela; Tenelisiwe Dlamini; Siphiwe Sithole; Sandile Malaza; Sikhumbuzo Dlamini; Daniel Afriyie; George Awuku Asare; Seth Kwabena Amponsah; Israel Sefah; Margaret Oluka; Anastasia N Guantai; Sylvia A Opanga; Tebello Violet Sarele; Refeletse Keabetsoe Mafisa; Ibrahim Chikowe; Felix Khuluza; Dan Kibuule; Francis Kalemeera; Mwangana Mubita; Joseph Fadare; Laurien Sibomana; Gwendoline Malegwale Ramokgopa; Carmen Whyte; Tshegofatso Maimela; Johannes Hugo; Johanna C Meyer; Natalie Schellack; Enos M Rampamba; Adel Visser; Abubakr Alfadl; Elfatih M Malik; Oliver Ombeva Malande; Aubrey C Kalungia; Chiluba Mwila; Trust Zaranyika; Blessmore Vimbai Chaibva; Ioana D Olaru; Nyasha Masuka; Janney Wale; Lenias Hwenda; Regina Kamoga; Ruaraidh Hill; Corrado Barbui; Tomasz Bochenek; Amanj Kurdi; Stephen Campbell; Antony P Martin; Thuy Nguyen Thi Phuong; Binh Nguyen Thanh; Brian Godman
Journal:  Front Pharmacol       Date:  2020-09-11       Impact factor: 5.810

2.  Evaluation of the effect of border closure on COVID-19 incidence rates across nine African countries: an interrupted time series study.

Authors:  Theophilus I Emeto; Faith O Alele; Olayinka S Ilesanmi
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-03-05       Impact factor: 2.184

3.  Identifying and combating the impacts of COVID-19 on malaria.

Authors:  Stephen J Rogerson; James G Beeson; Moses Laman; Jeanne Rini Poespoprodjo; Timothy William; Julie A Simpson; Ric N Price
Journal:  BMC Med       Date:  2020-07-30       Impact factor: 8.775

4.  Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review.

Authors:  Berihun Assefa Dachew; Akilew Awoke Adane; Hailay Abrha Gesesew; Digsu Negese Koye; Dagnachew Muluye Fetene; Mulu Woldegiorgis; Yohannes Kinfu; Ayele Bali Geleto; Yohannes Adama Melaku; Hassen Mohammed; Kefyalew Addis Alene; Mamaru Ayenew Awoke; Mulugeta Molla Birhanu; Amanuel Tesfay Gebremedhin; Yalemzewod Assefa Gelaw; Desalegn Markos Shifti; Muluken Dessalegn Muluneh; Teketo Kassaw Tegegne; Solomon Abrha; Atsede Fantahun Aregay; Mohammed Biset Ayalew; Abadi Kahsu Gebre; Kidane Tadesse Gebremariam; Tesfaye Gebremedhin; Lemlem Gebremichael; Cheru Tesema Leshargie; Getiye Dejenu Kibret; Maereg Wagnew Meazaw; Alemayehu Berhane Mekonnen; Dejen Yemane Tekle; Azeb Gebresilassie Tesema; Fisaha Haile Tesfay; Wubshet Tesfaye; Befikadu Legesse Wubishet
Journal:  BMJ Open       Date:  2021-02-18       Impact factor: 2.692

5.  Clinical and Demographic Characteristics of COVID-19 patients in Lagos, Nigeria: A Descriptive Study.

Authors:  Ngozi Mirabel Otuonye; Testimony Jesupamilerin Olumade; Mercy Mayowa Ojetunde; Susan Abba Holdbrooke; Joy Boluwatife Ayoola; Itse Yusuf Nyam; Bamidele Iwalokun; Chika Onwuamah; Mabel Uwandu; Akinola Abayomi; Akin Osibogun; Abimbola Bowale; Bodunrin Osikomaiya; Babafemi Thomas; Bamidele Mutiu; Nkiruka Nnonyelum Odunukwe
Journal:  J Natl Med Assoc       Date:  2020-12-22       Impact factor: 1.798

Review 6.  Sickle cell disease and COVID-19: Susceptibility and severity.

Authors:  Babak Sayad; Mehran Karimi; Zohreh Rahimi
Journal:  Pediatr Blood Cancer       Date:  2021-06-01       Impact factor: 3.838

7.  From Preparedness to Recovery: Learning Lessons Of COVID-19 Outbreak from China.

Authors:  Charles Nsanzabera; Leonard Ndayisenga; Jean Damascene Kabakambira; Felix Hagenimana
Journal:  East Afr Health Res J       Date:  2020-06-26

8.  Population risk factors for COVID-19 deaths in Nigeria at sub-national level.

Authors:  Zubaida Hassan; Muhammad Jawad Hashim; Gulfaraz Khan
Journal:  Pan Afr Med J       Date:  2020-08-04

Review 9.  Addressing Africa's pandemic puzzle: Perspectives on COVID-19 transmission and mortality in sub-Saharan Africa.

Authors:  Hassan H Musa; Taha H Musa; Idriss H Musa; Ibrahim H Musa; Alessia Ranciaro; Michael C Campbell
Journal:  Int J Infect Dis       Date:  2020-09-30       Impact factor: 3.623

10.  Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19.

Authors:  Chukwudi Arnest Nnaji; Charles Shey Wiysonge
Journal:  Pan Afr Med J       Date:  2020-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.